Arab World vs Belgium: Antiretroviral therapy coverage
Arab World
48.5%
in 2024
Belgium
88.0%
in 2023
Arab World rank
20th
Belgium rank
23rd
Antiretroviral therapy coverage over time
- Arab World
- Belgium
How they compare
Belgium currently reports 88.0% against 48.5% in Arab World, a difference of 39.5%.
That makes Belgium's figure about 1.8 times Arab World's.
Across all 24 years both countries report, Belgium has been ahead every year.
Arab World ranks 20th and Belgium ranks 23rd of 23 groups.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.4% | 54.8% | 49.4% | Belgium |
| 2010s | 25.3% | 85.0% | 59.7% | Belgium |
| 2020s | 43.9% | 87.8% | 43.9% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Arab World or Belgium?
- Belgium, at 88.0% against 48.5% in Arab World as of 2023.
- What is the difference in antiretroviral therapy coverage between Arab World and Belgium?
- 39.5%, with Belgium ahead.
- How many years of comparable data are there for Arab World and Belgium?
- 24 years are reported by both, from 2000 to 2023.
- How do Arab World and Belgium rank globally for antiretroviral therapy coverage?
- Arab World ranks 20th and Belgium ranks 23rd of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.